615.665.7100
Company Overview
BreatheAmerica, Inc. is a company dedicated to improving how healthcare services are delivered to patients who suffer from chronic airway diseases - allergy, sinusitis, asthma and other related diseases - with the goal of improving outcomes, reducing healthcare expenditures, and delivering an exceptional, differentiated patient experience.
BreatheAmerica has developed a unique clinical and operational model that we believe makes a significant impact on the delivery of healthcare for patients who suffer from airway disease.
BreatheAmerica will implement its program across the country transforming allergy practices to outpatient based airway disease centers. Integral components of our model include:
- A physician led organization that makes nurse practitioners available for extensive interaction with patients
- Assembling in one location, the full array of clinical resources necessary to thoroughly diagnose, treat and manage the disease
- The utilization of evidence based protocols to guide our multidisciplinary team
- A comprehensive focus on airway disease and it's root causes - not just episodic care
- A concentration on education and collaboration among physicians, nurse practitioners and patients to bring about needed life style changes
Please contact us for more information about BreatheAmerica.
Allergic diseases affect as many as 40 to 50 million Americans.
Immunotherapy helps reduce hay fever symptoms in about 85% of people with allergic rhinitis.
Sinusitis is one of the leading forms of chronic disease, with an estimated 18 million cases and at least 30 million courses of antibiotics per year.
In a survey of U.S. homes, approximately 25% had levels of dust mites high enough to trigger asthma symptoms.